HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone marrow transplantation in chronic granulomatous disease.

AbstractUNLABELLED:
We present a 5-year-old boy with a severe form of X-linked chronic granulomatous disease and hypersensitivity to sulphamides preventing prophylaxis with trimethoprim-sulphomethoxazole. Bone marrow transplantation was performed after preconditioning with busulphan and cyclophosphamide. The immediate post-transplant period was without complications. Complete chimerism was demonstrated and post-transplant oxidative metabolism was normal. The patient is asymptomatic 30 months after the graft.
CONCLUSION:
Bone marrow transplantation in cases of chronic granulomatous disease is controversial, although it could be useful in selected very severe cases in which prophylactic therapy is problematic.
AuthorsM C Calviño, M S Maldonado, E Otheo, A Muñoz, J M Couselo, C Burgaleta
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 155 Issue 10 Pg. 877-9 (Oct 1996) ISSN: 0340-6199 [Print] Germany
PMID8891557 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Busulfan
Topics
  • Bone Marrow Transplantation
  • Busulfan (administration & dosage)
  • Child, Preschool
  • Cyclophosphamide (administration & dosage)
  • Granulomatous Disease, Chronic (genetics, immunology, therapy)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: